Peptide Surfaces for Pluripotent Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing pluripotent cells, such as embryonic stem cells, face challenges in maintaining long-term growth and differentiation on chemically defined surfaces without using animal products or undefined extracellular matrix proteins, which often lead to rapid differentiation and batch variability.
Innovation Solution
Development of insoluble substrates with chemically defined surfaces presenting peptides that bind to glycosaminoglycans, specifically GAG-binding peptides with positively charged amino acid residues, which support long-term culture and separation of differentiated cells from undifferentiated ones, using a combination of synthetic peptides and kinase inhibitors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If gelatin-coated surfaces with feeder cells are used, then pluripotent cells can be cultured, but the cells tend to occupy the exposed surface and push feeder cells away, leading to loss of feeder cell support
Solution Approach 1:
The patent extracts the essential function of feeder cells (secretion of growth factors and extracellular matrix proteins) and transfers it to a chemically defined medium containing recombinant human proteins (albumin, insulin, transferrin, and growth factors). This eliminates the need for animal-derived gelatin and feeder cells while maintaining reliable pluripotent cell culture
Solution Approach 2:
The patent changes the chemical composition parameters of the culture system by replacing undefined gelatin and feeder cell secretions with precisely defined concentrations of recombinant human proteins and growth factors, achieving both reliability and operational control
2Ease of operation
If conditioned medium from feeder cells is used, then feeder-free culture is achieved, but rapid differentiation of pluripotent cells occurs
Solution Approach 1:
The patent modifies the chemical parameters of the culture medium by replacing conditioned medium with a chemically defined medium containing specific concentrations of recombinant human albumin, insulin, transferrin, and growth factors (bFGF, IGF-1, TGF-β), which maintains pluripotent cell undifferentiated state
Solution Approach 2:
The patent creates a composite culture medium system combining multiple recombinant human proteins and growth factors that work synergistically to maintain pluripotent cells in an undifferentiated state without feeder cells
3Ease of operation
If chemically defined culture medium is used, then feeder-independent culture is achieved, but surface attachment and cell survival are compromised
Solution Approach 1:
The patent introduces recombinant human extracellular matrix proteins (laminin, collagen, fibronectin, vitronectin) as intermediary substances that mediate cell attachment to the culture surface, replacing the attachment function previously provided by gelatin and feeder cells
Solution Approach 2:
The patent develops a composite culture system combining chemically defined medium with recombinant human proteins that provide both nutritional support and attachment functions, achieving feeder-independent culture with maintained cell survival
4Productivity
If animal products and undefined extracellular matrix proteins are used, then cell growth is supported, but batch variability and contamination risks increase
Solution Approach 1:
The patent replaces expensive, batch-variable animal-derived products with recombinant human proteins produced in controlled systems, eliminating batch variability and contamination risks while maintaining cell growth support
Solution Approach 2:
The patent changes the source and composition parameters by using chemically defined concentrations of recombinant human proteins instead of undefined animal products, achieving consistent batch-to-batch results and improved safety
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chemically defined surfaces allow for the maintenance of pluripotent cells in an undifferentiated state for over three months, retaining normal karyotype and pluripotency markers, and enabling differentiation into all three germ layers, while minimizing exposure to hazardous contaminants and animal products.
Implementation Method 1
peptides that bind to glycosaminoglycans, specifically GAG-binding peptides with positively charged amino acid residues
Data Source
AI summary
The present invention relates to methods of growing and maintaining pluripotent cells on an insoluble substrate that presents a peptide that binds to glycosaminoglycans, such as heparin. Specifically, methods of growing and maintaining pluripotent cells on substrates having a chemically defined surface presenting at least one peptide having basic amino acid residues separated by one or two hydrophobic amino acid residues.